How long can a person with lung cancer metastasis to lymph nodes live

How long can a patient live with lung cancer lymph node metastasis? Lung cancer lymph node metastasis is a common metastasis symptom in lung cancer patients. It is usually a clinical symptom that occurs in patients with advanced lung cancer. A small number of early patients may also have lymph node metastasis. In addition to lymph node metastasis, advanced lung cancer may also have bone metastasis, body metastasis, digestive tract metastasis, etc., which seriously threatens the patient's life.

The survival rate of lung cancer lymph node metastasis depends on many factors, including the patient's physical condition, tumor pathological type, tumor size and the correct choice of treatment method.

Generally speaking, the survival rate of early stage lung cancer with lymph node metastasis is higher, while patients in the middle and late stages have a lower chance of being cured due to their more serious condition and poor physical constitution, and the tumor may infiltrate locally or metastasize throughout the body. Surgery is not very meaningful in the treatment of lung cancer lymph node metastasis, and a comprehensive treatment plan is generally adopted clinically.

In addition to surgical treatment, chemotherapy has significant short-term efficacy among conventional treatments, but it is often accompanied by obvious toxic and side effects, and the local tumor remission period is short, and the quality of life is poor, which is not very helpful for the long-term survival of patients. Therefore, clinically, patients can be advised to adopt highly targeted tumor multicellular biological treatment, which can improve the patient's autonomous anti-cancer immune ability, regulate and enhance the patient's autonomous immune function, and inhibit and kill tumor cells. Combined chemotherapy can enhance the efficacy of chemotherapy, reduce the toxic and side effects of chemotherapy, improve the patient's overall physical condition, improve the patient's quality of life, and prolong the patient's effective survival period, with significant long-term efficacy.

Because lung cancer lymph node metastasis has already shown metastatic symptoms, the principle of treatment should be to control the patient's condition, prevent tumor cells from spreading and metastasizing again, and prolong the patient's effective survival period as the main treatment purpose. Tumor biotherapy, as a systemic treatment method, can be used throughout the entire treatment process of lung cancer. It plays a good role in controlling the continued spread and metastasis of lung cancer lymph node metastasis, blocking the spread and metastasis of cancer cells, and controlling the patient's condition in order to achieve the long-term goal of "long-term survival with cancer" and improve the survival rate of lung cancer.

For patients with metastatic cancer, especially those with distant metastasis, treatment should focus on comprehensive systemic treatment plans to ensure the effectiveness of treatment and prolong the patient's life. However, the survival period of each patient should be determined based on the patient's specific condition and cannot be generalized.